What & #039;s Next for Bioresorbable Scaffolds?
Even with new data, the future of bioresorbable scaffolds remains in flux. At TCT 2018 in September, Reva Medical and Abbott Laboratories painted differing pictures with their respective bioresorbable scaffold studies. What now? Dr. Lukasz Koltowski from the Medical University of Warsaw in Warsaw, Poland, presented new data from Reva Medical's "Fantom STEMI" pilot study. The study showed procedural success and clinical utility of the Fantom bioresorbable scaffold in nine patients with acute ST-segment elevated myocardial infarction (“STEMI”) heart attacks. "Many heart atta...
Source: MDDI - October 16, 2018 Category: Medical Devices Authors: Heather R. Johnson Tags: Business Cardiovascular Source Type: news

Prevention of venous thromboembolic complications in firearm injury - Nikolaev KN, Zubritsky VF, Koltovich AP, Vardanyan AV, Kapustin SI, Dolidze DD, Vardanyan VA.
Prevention of venous thromboembolic complications in wounded is a complex problem which has not yet been fully resolved throughout the world. Current state of venous thrombosis prevention in wounded in different countries and certain ways of its improvemen... (Source: SafetyLit)
Source: SafetyLit - October 15, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Rwanda:Rwandan Activist to Be Feted On World Thrombosis Day
[New Times] Christine Ashimwe, the founder of Rwanda Clot Awareness Network, has received a prestigious award for thrombosis advocacy achievements by the International Society on Thrombosis and Haemotasis (ISTH). (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 12, 2018 Category: African Health Source Type: news

Residual Vein Obstruction Down With Compression After DVT
RVO less likely for those receiving compression within 24 hours of diagnosis of deep vein thrombosis (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 4, 2018 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Pulmonology, Journal, Source Type: news

Residual Vein Obstruction Down With Compression After DVT
THURSDAY, Oct. 4, 2018 -- The likelihood of residual vein obstruction (RVO) is reduced with immediate compression after diagnosis of deep vein thrombosis, according to a study published online Sept. 24 in Blood. Elham E. Amin, from Maastricht... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 4, 2018 Category: Pharmaceuticals Source Type: news

Risk of Venous Thromboembolism Recurrence High
At 6 months, rates for provoked, unprovoked, cancer - related VTE are 6.8, 6.92, 9.06 per 100 person - years (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 1, 2018 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, Internal Medicine, Critical Care, Nephrology, Neurology, Oncology, Orthopedics, Pharmacy, Pulmonology, Rheumatology, Surgery, Journal, Source Type: news

Anticoagulation for people with cancer and central venous catheters
This review found moderate-certainty evidence that LMWH reduces catheter ‐related venous thromboembolism (CR-VTE); evidence was inconclusive for LMWH effects on mortality and effects of vitamin K antagonists (VKA) on mortality or CR-VTE, and for LMWH versus VKA. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 28, 2018 Category: Consumer Health News Source Type: news

Venous Thromboembolism: Very Troubling Events Venous Thromboembolism: Very Troubling Events
Find out what nurses need to know about the risk assessment, prevention, and treatment of this potentially deadly condition.American Nurse Today (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 27, 2018 Category: Consumer Health News Tags: Nursing Journal Article Source Type: news

TCT: Lab Study Questions Washing Protocols for Bioprosthetic Heart Valves
(MedPage Today) -- Suggests increased leaflet thrombosis risk when storage solutions are rinsed away pre-implant (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - September 26, 2018 Category: Urology & Nephrology Source Type: news

Are You Tall? Better Watch Out For Varicose Veins
(CNN) — In what researchers are calling “the largest genetic study ever performed” on varicose vein disease, a Stanford University School of Medicine study found a person’s height to be a significant risk factor for developing varicose veins. “We not only found an association between height and varicose veins, but the genetic studies we did showed a causal link,” said cardiologist and study author Dr. Nicholas Leeper, an associate professor of surgery and cardiovascular medicine at Stanford. “That suggests that the genes and pathways that drive human height are also likely to be ca...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 24, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV Varicose Veins Source Type: news

What Causes Hyperkalemia?
Discussion Potassium (K+) is an alkali metal (Group 1 of periodic table with Hydrogen, Lithium and Sodium) with an anatomic number of 19. Its chemical symbol K, comes from the medieval Latin, kalium which means potash (mainly potassium carbonate or potassium hydroxide), the substance it was first isolated from. Potassium is an important cation and it mainly resides in the intracellular fluid with only a small amount in the extracellular fluid. Potassium regulates cell volume, pH and enzyme functions. Hyperkalemia is defined as a potassium level> 5.5 mEq/L in children and> 6.0 mEq/L in newborns. Hyperkalemia incre...
Source: PediatricEducation.org - September 24, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

' Ridiculous' (in a Good Way) Results With Novel Stent'Ridiculous' (in a Good Way) Results With Novel Stent
Both BIONYX and SORT OUT IX trials showed Resolute Onyx and BioFreedom stents noninferior to the Orsiro device, but stent thrombosis with Resolute Onyx was called'ridiculously low'by one commentator.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 23, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

No Clear Benefit for Rivaroxaban After Hospital Discharge
WEDNESDAY, Sept. 19, 2018 -- Rivaroxaban does not lower risk of symptomatic venous thromboembolism and related death in medical patients after hospital discharge, compared to placebo, according to a study published in the Sept. 20 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 19, 2018 Category: Pharmaceuticals Source Type: news

DVT (Deep Vein Thrombosis) During Pregnancy
Title: DVT (Deep Vein Thrombosis) During PregnancyCategory: Diseases and ConditionsCreated: 9/18/2018 12:00:00 AMLast Editorial Review: 9/18/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 18, 2018 Category: Cardiology Source Type: news

Antimicrobial lock solutions for preventing catheterrelated infections in haemodialysis
This systematic review of 39 studies (n=4216) found antibiotic antimicrobial and combined (antibiotic ‐non antibiotic) lock solutions (LSs) decreased incidence of catheter‐related infection compared to control LSs. The effect on thrombosis incidence is uncertain for all antimicrobial LSs. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 12, 2018 Category: Consumer Health News Source Type: news

ME & MY OPERATION: New procedure to give you perfect pins after a painful blood clot
60,000 people a year develop a deep vein thrombosis - and Wendy Yaxley, 53, from Lincoln, was one of them. This is her story of pioneering new treatment. (Source: the Mail online | Health)
Source: the Mail online | Health - September 10, 2018 Category: Consumer Health News Source Type: news

Medtronic launches one-month DAPT study for drug-eluting stent in U.S., Japan
Medtronic (NYSE:MDT) said today that it’s launching a study in the U.S. and Japan to evaluate dual antiplatelet therapy in high bleeding risk patients implanted with the Resolute Onyx drug-eluting stent during percutaneous coronary intervention. The company’s Onyx One Clear study is one of the first designed to assess the risk of cardiac death and stent thrombosis following DAPT interruption or discontinuation after one month with a next-gen drug-eluting stent, according to Medtronic. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic launches one-month DAPT study for dr...
Source: Mass Device - September 10, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Drug-Device Combinations Drug-Eluting Stents Pharmaceuticals Wall Street Beat Medtronic Source Type: news

Medical News Today: Why does olive oil keep heart attack and stroke at bay?
A new study shows that the protein ApoA-IV, which rises in the blood after eating (especially unsaturated fats), prevents thrombosis by blocking platelets. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 7, 2018 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

How olive oil and sleep could stave off heart attacks and strokes: New study examines plasma protein’s role
Apolipoprotein A-IV linked with thrombosis in new study (Source: St. Michael's Hospital News and Media)
Source: St. Michael's Hospital News and Media - September 6, 2018 Category: Hospital Management Tags: Hospital News Source Type: news

An Allergy to Red Meat May Be Tied to Heart Disease
FRIDAY, Aug. 31, 2018 -- An allergen in red meat may be tied to heart disease, according to a study published in the July issue of Arteriosclerosis, Thrombosis, and Vascular Biology. Jeffrey M. Wilson, M.D., Ph.D., from the University of Virginia in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 31, 2018 Category: Pharmaceuticals Source Type: news

No Reduction in VTE, Death With Rivaroxaban Post-Discharge No Reduction in VTE, Death With Rivaroxaban Post-Discharge
MARINER trial results showed no benefit in reducing a composite of symptomatic venous thromboembolism and death after discharge in high-risk hospitalized patients, although bleeding risk was also low.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 26, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Airplane-induced blood clots are more common than you think: Know the signs and what you can do to prevent them
(Natural News) While air travel has made many an advancement in the past decades, it’s still not completely safe. One major risk long-distance flyers take when airborne is blood clots, specifically, a type of blood clot known as deep vein thrombosis or DVT. These blood clots form in veins deep within the body, usually the... (Source: NaturalNews.com)
Source: NaturalNews.com - August 23, 2018 Category: Consumer Health News Source Type: news

Access Vascular raises $3m for anti-clot PICC technology
Access Vascular raised more than $3 million from a consortium of new and existing investors that CEO Jim Biggins said should be sufficient to carry the company through a post-market clinical evaluation of its HyrdoPICC catheter and into the regulatory process for its next iteration. Biggins told MassDevice.com yesterday that the $3.4 million round was led by a “family office in the Boston area” that’s backed Access since its 2015 inception. “They’ve been supporting us since the beginning of the company and they helped price and lead this most recent round,” he told us, adding t...
Source: Mass Device - August 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Catheters Funding Roundup Vascular Wall Street Beat accessvascular Source Type: news

An Overlooked Risk Factor for Venous Thromboembolism? An Overlooked Risk Factor for Venous Thromboembolism?
A new meta-analysis identifies a drug class that's linked with thromboembolism.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 22, 2018 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

VTE Risk May Hurt Survival After Kidney Cancer Surgery
All-cause mortality was significantly higher among renal cell carcinoma (RCC) patients who developed symptomatic venous thromboembolism (VTE) after undergoing nephrectomy and inferior vena cava (IVC) tumor thrombectomy (TT) accompanied by intravascular tumor thrombosis, a retrospective analysis showed.08/20/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 20, 2018 Category: Urology & Nephrology Source Type: news

VTE Risk May Hurt Survival After Kidney Cancer Surgery
(MedPage Today) -- Multiple factors seen worsening thromboembolism problem (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 18, 2018 Category: Cardiology Source Type: news

CVST After Vestibular Schwannoma Surgery CVST After Vestibular Schwannoma Surgery
In this review, the authors report on their management experience of postoperative cerebral venous sinus thrombosis, an infrequent complication after vestibular schwannoma surgery.Neurosurgical Focus (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 17, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Hancock Jaffe steps closer to launching Colombian VenoValve trial
Hancock Jaffe Laboratories (NSDQ:HJLI) said today it won approval from Colombia’s Medical Research Committee at Fundación Santa Fe de Bogotá to launch a first-in-human trial of its VenoValve bioprosthetic valve. The Irvine, Calif.-based company’s VenoValve is a porcine valve designed to be implanted into the femoral or popliteal vein to treat lower limb chronic venous insufficiency from damage to leg vein valves after deep vein thrombosis. The company said that with the approval, it will begin to gather data necessary to submit an application to Colombia’s FDA equivalent, the Insti...
Source: Mass Device - August 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Vascular hancockjaffelabs Source Type: news

Cleveland Clinic researchers receive $4.7 million NIH grant to prevent cancer-associated thrombosis
(Cleveland Clinic) The National Heart, Lung and Blood Institute, part of the National Institutes of Health, awarded a $4.7 million grant to Cleveland Clinic to study the prevention of life-threatening, cancer-associated blood clots. The new funding will support a Cleveland Clinic-led research consortium, which will focus on developing strategies to prevent cancer-associated thrombosis (blood clot formation), a potential side effect of cancer treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 8, 2018 Category: Cancer & Oncology Source Type: news

' Good' Cholesterol May Not Be So in Postmenopausal Women
TUESDAY, Aug. 7, 2018 -- Elevated high-density lipoprotein cholesterol (HDL-C) may not always be cardioprotective in postmenopausal women, according to a study published online July 19 in Arteriosclerosis, Thrombosis, and Vascular Biology. Samar R.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 7, 2018 Category: Pharmaceuticals Source Type: news

Cardiovascular Risks Elevated in Transgender Women
(MedPage Today) -- Estrogen use tied to over fivefold increase in venous thromboembolism risk (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 6, 2018 Category: American Health Source Type: news

NextGen Medical targets clots in large vessels
NexGen Medical Systems announced the successful completion of the first human use of its XCOIL  large vessel (18mm) thrombectomy system for the treatment of deep vein thrombosis (DVT). The new device represents an expansion of the company’s 12mm XCOIL system and is designed to rapidly remove blood clots in large vessels, such as the iliac vein. Both XCOIL systems are comprised of an encapsulator sheath and a retractor catheter. The retractor is used to engage and extract the clot, pull it into the encapsulator and remove the clot from the body while minimizing the need for clot-dissolving lytic dr...
Source: Mass Device - August 6, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Cardiovascular nextgenmedical Source Type: news

LSU health research discovers new link between hypoxia and blood clot risk
(Louisiana State University Health Sciences Center) Research led by Rinku Majumder, PhD, Associate Professor of Biochemistry at LSU Health New Orleans School of Medicine, has found how hypoxia (a low concentration of oxygen) decreases Protein S, a natural anticoagulant, resulting in an increased risk for the development of potentially life-threatening blood clots (thrombosis). Although hypoxia has been associated with an increased risk for thrombosis, this research showed for the first time a molecular cause. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 2, 2018 Category: Cancer & Oncology Source Type: news

Antidepressants, Depression Tied to Increased Thromboembolism Risk Antidepressants, Depression Tied to Increased Thromboembolism Risk
The first meta-analysis of its kind shows that antidepressants and depression are both associated with an increased risk for venous thromboembolism. However, the results should be interpreted with caution.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 27, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

VTE Prophylaxis After Gastrectomy May Boost Bleeding in Asian Patients VTE Prophylaxis After Gastrectomy May Boost Bleeding in Asian Patients
In Asian patients, symptomatic venous thromboembolism (VTE) after gastrectomy is extremely rare, and pharmacological prophylactic measures may prompt bleeding complications, Korean researchers say.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - July 27, 2018 Category: Radiology Tags: General Surgery News Source Type: news

Hancock Jaffe wins OK from ethics committee for FIH VenoValve trial
Hancock Jaffe Laboratories (NSDQ:HJLI) said today that Colombia’s Ethics Committee at Fundación Santa Fe de Bogotá approved a first-in-human trial of its VenoValve bioprosthetic valve. The Irvine, Calif.-based company’s VenoValve is a porcine valve designed to be implanted into the femoral or popliteal vein to treat lower limb chronic venous insufficiency from damage to leg vein valves after deep vein thrombosis. Hancock Jaffe said that it is also waiting for approval from the FSFB’s medical research committee to launch the trial, according to a press release. Last month, the under...
Source: Mass Device - July 24, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Regulatory/Compliance Vascular hancockjaffelabs Source Type: news

Depression and antidepressants are associated with an increased risk of venous thromboembolism
In the first review of its kind, new research has found that depression and the use of antidepressants are each associated with an increased risk of venous thromboembolism (VTE). The study led by academics from the Musculoskeletal Research Unit at the University of Bristol has also shown that each of the various classes of antidepressant medications are associated with an increased risk of VTE. (Source: University of Bristol news)
Source: University of Bristol news - July 24, 2018 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Translational Health Sciences; Press Release Source Type: news

Depression and antidepressants are associated with an increased risk of VTE
(University of Bristol) In the first review of its kind, new research has found that depression and the use of antidepressants are each associated with an increased risk of venous thromboembolism (VTE). The study led by academics from the Musculoskeletal Research Unit at the University of Bristol has also shown that each of the various classes of antidepressant medications are associated with an increased risk of VTE. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2018 Category: International Medicine & Public Health Source Type: news

DOACs May Cut Cranial Bleed Risk, Up Survival in Women With AF DOACs May Cut Cranial Bleed Risk, Up Survival in Women With AF
Female sex increases the risk for thromboembolism when other risk factors are present, and perhaps in the future, patient sex may be considered to guide AF therapy choices, says one expert.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Trial Adds Gemcitabine to Pleural Mesothelioma HIOC Therapy
Results of a phase I clinical trial highlight how the addition of a drug to an existing treatment option appears safe and may improve outcomes in certain patients with malignant pleural mesothelioma (MPM). The primary goal of the trial was to determine the maximum tolerated dose of gemcitabine added to cisplatin when these drugs are delivered together as heated intraoperative chemotherapy (HIOC) during surgery. Researchers have studied cisplatin alone for HIOC. The addition of gemcitabine — a chemotherapy drug often used to treat pancreatic, ovarian and breast cancers — is new. The Journal of Thoracic Oncology...
Source: Asbestos and Mesothelioma News - July 18, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Increased Mortality With Vena Cava Filters Stirs Controversy Increased Mortality With Vena Cava Filters Stirs Controversy
The use of vena cava filters in patients with venous thromboembolism and a contraindication to anticoagulation is associated with an increase in 30-day mortality, results of a new observational show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

How fast can acute stroke treatment become to still be reliable?
(University of Helsinki) Neurologists around the world are aware that the delivery of thrombolytic treatment for stroke in Helsinki University Hospital, Finland, is freaking fast -- but is it too fast? A new study published on July 11 in the journal Neurology clarified whether the team of neurologists in Helsinki actually have enough time to diagnose stroke correctly before it is treated. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2018 Category: International Medicine & Public Health Source Type: news

Transgender Women at High Risk of Thromboembolism, Stroke Transgender Women at High Risk of Thromboembolism, Stroke
Cross-sex estrogen taken by transgender women appears to increase the risk of thromboembolism in a way that seems very different from that observed when postmenopausal women take HRT.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 11, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

AngioDynamics takes a hit after missing Q4 numbers
AngioDynamics (NSDQ:ANGO) failed to meet expectations for its fiscal fourth quarter, sending share prices sharply down today despite a swing to black ink. Latham, N.Y.-based AngioDynamics posted profits of $2.1 million, or 6¢ per share, on sales of $88.3 million for the three months ended May 31. That compares with losses of -$12.9 million during fiscal Q4 2017 and amounts to top-line growth of 1.6%. Adjusted to exclude one-time items, earnings per share were 20¢, a penny below the consensus forecast on Wall Street, where analysts were looking for sales of $89.3 million. Full-year profits surged 226.2% to $1...
Source: Mass Device - July 11, 2018 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Wall Street Beat AngioDynamics Source Type: news

Transfeminine Persons Have Increased VTE Incidence
TUESDAY, July 10, 2018 -- Transfeminine individuals have increased rates of venous thromboembolism (VTE) compared with cisgender men and cisgender women, with more pronounced differences for those initiating hormone therapy, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 10, 2018 Category: Pharmaceuticals Source Type: news

ASH to collaborate on clinical practice guidelines on von Willebrand Disease
(American Society of Hematology) The American Society of Hematology (ASH) will collaborate with the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), World Federation of Hemophilia (WFH), and the University of Kansas Medical Center to develop clinical practice guidelines on the diagnosis and management of von Willebrand Disease (VWD).   (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 21, 2018 Category: International Medicine & Public Health Source Type: news

Early TAVR Leaflet Thrombosis Not Harmful, Study Says (CME/CE)
(MedPage Today) -- Single-center series, with anticoagulant Tx for most, leaves open questions (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 20, 2018 Category: Cardiology Source Type: news

DVT symptoms: Four signs of deep vein thrombosis to watch for when you fly this summer
DVT, which stands for deep vein thrombosis, is when a blood clot develops within a deep vein in the body, usually in the leg. The condition has long being associated with flying and the complications can be fatal. So what symptoms and signs should you watch out for when you fly away on your holiday this summer? (Source: Daily Express - Health)
Source: Daily Express - Health - June 19, 2018 Category: Consumer Health News Source Type: news

Are YOU at risk of developing a shock blood clot from flying?
Travel-related deep vein thrombosis (DVT) has remained a hot topic ever since the link with long-haul flights was first recognized in the last 10 years. Dr Sarah Brewer lays out the risk factors. (Source: the Mail online | Health)
Source: the Mail online | Health - June 18, 2018 Category: Consumer Health News Source Type: news

Over-allotment takes Hancock Jaffe IPO to nearly $9m
The underwriter of an initial public offering by Hancock Jaffe Laboratories (NSDQ:HJLI) this week exercised in full its over-allotment option, taking the gross proceeds from the flotation to nearly $9 million. The IPO, which priced on the last day of May, initially brought in $7.5 million for Irvine, Calif.-based Hancock Jaffe, which makes bioprosthetic implants designed to treat chronic deep vein insufficiency, heart valve conditions and coronary artery bypass grafts. The shares trade on the NASDAQ exchange under the symbol “HJLI.” Network 1 Financial Securities, the offering’s managi...
Source: Mass Device - June 15, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Vascular Wall Street Beat hancockjaffelabs Source Type: news